Results 101 to 110 of about 53,966 (218)

Delayed recurrent hyphema following trabeculectomy: A case series of swan syndrome managed with anti-VEGF therapy

open access: yesIndian Journal of Ophthalmology. Case Reports
Swan syndrome refers to delayed recurrent intraocular bleeding caused by vascular ingrowth at the site of a prior surgical wound. Although classically described after cataract surgery, it has rarely been reported following trabeculectomy. We report three
Priyanka Sudhakar   +2 more
doaj   +1 more source

Pneumatic displacement with intravitreal bevacizumab for massive submacular hemorrhage due to polypoidal choroidal vasculopathy

open access: yes, 2014
Masayasu Kitahashi,1 Takayuki Baba,1 Madoka Sakurai,1 Hirotaka Yokouchi,1 Mariko Kubota-Taniai,1 Yoshinori Mitamura,2 Shuichi Yamamoto1 1Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Chiba, 2Institute of ...
Yokouchi H   +6 more
core  

Risk ratio of systemic adverse events associated with intravitreal bevacizumab compared with ranibizumab.

open access: yes, 2014
Risk ratio of systemic adverse events associated with intravitreal bevacizumab compared with ranibizumab.
Xiulan Zhang (142434), Wei Wang (17594)
core   +1 more source

Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma

open access: yes, 2015
Tadanobu Yoshikawa, Kanji Takahashi Department of Ophthalmology, Kansai Medical University, Osaka, Japan Purpose: To describe the outcomes of intravitreal injections of bevacizumab for choroidal neovascularization (CNV) associated with choroidal ...
Yoshikawa T, Takahashi K
core  

Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy

open access: yes, 2009
Ashraf M El-BatarnyAssistant Professor of Ophthalmology, Tanta University, Egypt; Chief of Vitreoretinal Service, Magrabi Eye and Ear Hospital, Muscat, Sultanate of OmanPurpose: To evaluate the effect of intravitreal injection of Avastin, bevacizumab ...
Ashraf M El-Batarny
core  

Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab

open access: yes, 2009
To evaluate the course of treatment and outcomes of neovascular glaucoma (NVG) treated with intravitreal bevacizumab. The study is a retrospective, non-comparative, consecutive, interventional case series.
Palmberg, P F   +4 more
core   +1 more source

Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization

open access: yes, 2015
To report a patient with juxtapapillary choroidal osteoma (CO) with serous retinal detachment (SRD) not associated with choroidal neovascularization (CNV) who was successfully treated with a single intravitreal injection of bevacizumab.
Seyyed Moien Hendimarjan   +3 more
core   +1 more source

Aflibercept monotherapy or bevacizumab first for diabetic macular edema

open access: yesIndian Journal of Ophthalmology
Purpose: Clinical outcome and switch patterns with bevacizumab first treatment strategy for patients with newly diagnosed neovascular age-related macular degeneration (nAMD).
Avner Hostovsky   +2 more
doaj   +1 more source

Effect of intravitreal bevacizumab on diabetic macular edema with hard exudates

open access: yes, 2014
Sohee Jeon, Won Ki LeeDepartment of Ophthalmology, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, KoreaBackground: We evaluated the efficacy of intravitreal bevacizumab on diabetic macular edema with ...
Jeon S, Lee WK
core  

Management of Ruptured Retinal Arterial Macroaneurysm with Intravitreal Bevacizumab

open access: yes, 2010
The authors report the management of a ruptured retinal arterial macroaneurysm and associated hemorrhages with intravitreal injections of bevacizumab. A 79-year-old woman presented with a history of systemic arterial hypertension and a ruptured retinal ...
Golnaz Javey   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy